Showing results (171-180 of 208) with videos related to
Sort By:
Pageof 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2020
Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA-Mutant CancersKomal Jhaveri, Matthew T Chang, Dejan Juric, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2019
Phase I Study of the Novel Enhancer of Zeste Homolog 2 (EZH2) Inhibitor GSK2816126 in Patients with Advanced Hematologic and Solid TumorsTimothy A Yap, Jane N Winter, Lisa Giulino-Roth, et al.Blood Advances|July 17, 2020
Lenalidomide/rituximab induces high molecular response in untreated follicular lymphoma: LYSA ancillary RELEVANCE studyMarie-Helene Delfau-Larue, Marie-Laure Boulland, Asma Beldi-Ferchiou, et al.Leukemia|March 22, 2019
Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemiaNolwenn Lucas, Matthieu Duchmann, Philippe Rameau, et al.BMJ Supportive & Palliative Care|August 30, 2022
PALLIA 10 score in phase I cancer studiesKaïssa Ouali, Christine Mateus, Arianne Laparra, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 5, 2022
High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma NetworkOlivier Hermine, Linmiao Jiang, Jan Walewski, et al.Ejhaem|July 18, 2022
Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphomaLoretta J Nastoupil, John Kuruvilla, Julio C Chavez, et al.Cancers|September 28, 2021
Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 YearsMaxime Jullien, Benoit Tessoulin, Hervé Ghesquières, et al.Critical Reviews in Oncology/Hematology|November 25, 2023
Antibody drug conjugates in older patients: State of the artLayal Rached, Arthur Geraud, Maxime Frelaut, et al.The Lancet. Haematology|September 24, 2020
Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA groupSteven Le Gouill, Asma Beldi-Ferchiou, Marion Alcantara, et al.Pageof 21